For Research Partners

Institutional Access

PharmaOrder works with research laboratories, academic institutions, and institutional buyers to supply verified research compounds. Our platform streamlines bulk ordering for organizations that need reliable access to high-purity compounds with full COA documentation at competitive pricing.

Product Catalog

Institutional accounts have access to our full research catalog including GLP-1 receptor agonist compounds (PO-S01, PO-S02, PO-S03), peptide research compounds (BPC-157, NAD+, GHK-Cu, TB-500), growth hormone secretagogue compounds (Sermorelin, Tesamorelin, CJC-1295, Ipamorelin), and PDE5 inhibitor compounds (Tadalafil, Sildenafil). All products are for research use only.

Quality Assurance

Every product ships with a Certificate of Analysis documenting identity, purity via HPLC, and potency. Our supplier network is independently verified and each batch undergoes third-party testing. Full lot traceability is maintained for every product shipped.

Pricing & Ordering

Institutional pricing is available through our Account Manager program, which offers wholesale cost structures with customizable markup. Volume discounts are available for high-volume buyers. Contact our team to set up an institutional account.

Order Management

PharmaOrder supports bulk and recurring orders with order tracking, reorder workflows, and account-level reporting. Institutional buyers can manage multiple shipping addresses and payment methods through a single account.

Get Started

To set up an institutional account, contact us at support@pharmaorder.net with your organization name, research focus, and the products you are interested in. Our team will set up your account within 1-2 business days.

Featured Institutional Resources

GLP-1 Research Compounds for Institutions

A broader category page for institutional buyers comparing GLP-1 compound procurement workflows and considerations.

Open page →

PO-S01 for Research Facilities

A targeted overview of po-s01 compound supply, fulfillment, and quality considerations for research organizations.

Open page →

Last updated: March 2026